REQUEST A DEMO
Total
USD $0.00
Search more companies

FKP Shtelkovskii Biokombinat (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: FKP Shtelkovskii Biokombinat Profile Updated: August 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

FKP Shtelkovskii Biokombinat is an enterprise based in Russia. Its main office is in Moscow Oblast. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on September 27, 2002. The company’s latest financial report indicates a net sales revenue increase of 39.59% in 2022. Its’ total assets recorded a growth of 5.77%. The net profit margin of FKP Shtelkovskii Biokombinat increased by 1.41% in 2022.

Headquarters
Biokombinata
Moscow Oblast; Moscow Oblast; Postal Code: 141142

Contact Details: Purchase the FKP Shtelkovskii Biokombinat report to view the information.

Basic Information
Outstanding Shares:
Purchase the FKP Shtelkovskii Biokombinat report to view the information.
Registered Capital:
Purchase the FKP Shtelkovskii Biokombinat report to view the information.
Incorporation Date:
September 27, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after FKP Shtelkovskii Biokombinat report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
39.59%
Total operating revenue
39.59%
Operating profit (EBIT)
41.4%
Net Profit (Loss) for the Period
61.63%
Total assets
5.77%
Total equity
6.34%
Operating Profit Margin (ROS)
0.16%
Net Profit Margin
1.41%
Return on Equity (ROE)
1.92%
Quick Ratio
1.37%
Cash Ratio
2.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?